-
Cefodizime: Antibacterial Activity and Clinical Evidence
2026-09-03
The 1992 review by Barradell and Brogden integrated cefodizime’s in vitro spectrum, pharmacokinetics, host-defense effects, and clinical performance rather than treating susceptibility data in isolation. Its main contribution was showing how prolonged exposure and possible immunomodulatory activity could help explain clinical outcomes that appeared stronger than in vitro potency alone would predict.
-
Geneticin: Selection Logic for Mechanistic Assays
2026-09-03
Geneticin and G418 Sulfate are more than routine selection reagents: they can shape the biological context in which mechanistic assays are interpreted. This article connects translational inhibition, stable cell engineering, antiviral testing, and the CLK2–BRCA1 platinum-resistance model to improve experimental design.
-
Modeling AmpC/AmpD Resistance in P. aeruginosa
2026-09-02
Deroche et al. combined targeted bacterial genetics, sequential time-kill experiments, and semi-mechanistic PKPD modeling to separate the immediate and time-dependent effects of ampC and ampD mutations on ceftolozane-tazobactam resistance. The study shows that AmpC G183D and AmpD H157Y contribute differently and synergistically to resistance, while also altering imipenem susceptibility and adaptive-resistance behavior.
-
Vitamin D/VDR Control of Endometrial Decidualization
2026-09-02
This study identifies a vitamin D/VDR-dependent pathway that promotes human endometrial stromal cell decidualization through coordinated regulation of CYP19, ESR1, and estrogen signaling. Its combination of time-course analysis, VDR perturbation, primary-cell validation, and ChIP-qPCR provides a mechanistic framework for studying endometrial receptivity and infertility-related biology.
-
Cefodizime Workflows for Antibacterial Research
2026-09-01
Cefodizime provides a practical third-generation cephalosporin antibiotic platform for MIC testing, respiratory and urinary pathogen models, and resistance-focused experiments. This guide converts its PBP-directed mechanism, β-lactamase stability, and reported immunomodulatory behavior into reproducible workflows with controls and troubleshooting strategies.
-
Cefiderocol Activity Against Resistant Enterobacterales
2026-09-01
This European multicenter study evaluated cefiderocol against 1,909 Enterobacterales isolates, including organisms resistant to meropenem and approved β-lactam/β-lactamase inhibitor combinations. Its large, mechanism-informed comparison shows that cefiderocol retained high in vitro activity across several difficult resistance phenotypes, while also identifying iron-uptake, carbapenemase, and ftsI-associated changes among cefiderocol-resistant isolates.
-
BCA Protein Quantification Kit K4102
2026-08-31
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 provides sensitive total-protein measurement for dilute samples, including many detergent-containing biochemical preparations and cell lysates. It is intended for scientific research workflows such as sample normalization and is not validated for diagnostic, clinical, or medical testing.
-
(-)-Arctigenin: Mapping NF-κB in Tumor EVs
2026-08-31
Explore (-)-Arctigenin as a MEK1 inhibitor and iNOS-pathway probe in macrophage-derived extracellular vesicle research. This article translates breast cancer metastasis findings into a causal assay strategy while clearly separating established evidence from testable hypotheses.
-
Dimethyloxalylglycine (DMOG): Practical Guide
2026-08-30
Dimethyloxalylglycine (DMOG), SKU A4506, provides a cell-permeable chemical approach for investigating hypoxia-inducible factor stabilization and related oxygen-sensing responses in controlled laboratory models. This guide covers preparation, concentration selection, QC, and interpretation; the compound is for research use only and is not intended for diagnostic, therapeutic, or medical applications.
-
Gamithromycin PK/PD Cutoffs in Piglets
2026-08-29
Zhou et al. integrated epidemiological susceptibility testing, serum-based pharmacodynamics, population pharmacokinetics, and Monte Carlo simulation to define exposure targets for Gamithromycin against Haemophilus parasuis. The study identified an ECOFF of 1.0 mg/L, a PK/PD cutoff of 0.25 mg/L, and a calculated dose of 6.55 mg/kg for a target-attainment probability of at least 90%.
-
Sodium Dicloxacillin Monohydrate in MSSA Research
2026-08-28
A translational framework for using sodium dicloxacillin monohydrate in MSSA studies, connecting penicillin-binding protein biology with intracellular assays, free-drug PK/PD, environmental variables, and research workflow design.
-
Moxidectin in Antifungal Synergy Workflows
2026-08-28
Moxidectin is an established macrocyclic lactone anthelmintic with a developing research use as a polyene potentiator against Candida albicans. This workflow-focused guide covers stock preparation, checkerboard synergy testing, ergosterol validation, biofilm assays, and troubleshooting while separating promising laboratory evidence from clinical readiness.
-
Geneticin Workflows for Cell Selection and Virology
2026-08-27
Geneticin, also called G418 Sulfate, supports reproducible neomycin-resistance selection while offering a separate, model-dependent route for antiviral experiments. This guide connects reagent preparation, stable cell-line development, CRISPR host-factor studies, Dengue virus assays, and troubleshooting without confusing selection pressure with antiviral efficacy.
-
Anlotinib hydrochloride in Angiogenesis Assays
2026-08-27
Anlotinib hydrochloride provides a practical multi-target strategy for modeling angiogenesis driven by VEGF, PDGF-BB, or FGF-2. This guide translates receptor-level potency into reproducible migration, capillary tube formation, pathway-validation, and troubleshooting workflows for cancer research.
-
Mycophenolic Acid in Whole-Blood Immune Assays
2026-08-26
Mycophenolic acid enables controlled interrogation of nucleotide metabolism within standardized whole-blood stimulation assays. This guide connects stock preparation, cytokine workflows, assay controls, and troubleshooting to practical immunometabolism, apoptosis, and host-response research.